EUVIMEDEUVIMED entdecken
Crossref

Inhibitory Effect and Mechanism of Paclitaxel-Loaded Magnetic Iron Oxide Nanomicrobubbles Combined with Ultrasound Therapy on Breast Cancer Xenografts in Nude Mice

Weiyang Lv, Zihan Wang, Chunxin Huang, Xing Li, Lianjie Bai, Xiaotong Wang, Huilin Liu, Yunna Song, Bowen Liu, Xiaomei Ning iD

Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5250-5260

DOI: 10.1021/acs.molpharmaceut.5c01920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.09.2026. Verfasst von Weiyang Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Department, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar City, Heilongjiang Province161006, China. Hauptthemen laut MEDLINE: Paclitaxel, Breast Neoplasms, Ultrasonic Therapy, Magnetic Iron Oxide Nanoparticles. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Qiqihar Academy of Medical Sciences Clinical Research Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the therapeutic efficacy and underlying mechanisms of paclitaxel (PTX)-loaded magnetic iron oxide nanomicrobubbles (PTX@Fe3O4 NMBs) combined with ultrasound therapy in breast cancer xenograft models. The PTX@Fe3O4 NMBs were synthesised using a modified microfluidic approach and characterised for size, stability and drug loading. Female BALB/c nude mice bearing MCF-7 xenografts were randomly divided into five groups: control, free PTX (TPL), blank NMBs with ultrasound (TPL + US), targeted NMBs with ultrasound (TLUM + US) and combination therapy with ultrasound (FA-TLUM + US). Tumour growth was monitored for 21 days. Contrast-enhanced ultrasound imaging was performed to evaluate tumour perfusion. Apoptotic mechanisms were assessed through quantitative real-time polymerase chain reaction (PCR) and Western blotting. The PTX@Fe3O4 NMBs showed a mean diameter of 186 ± 15 nm, a polydispersity index value of 0.118, a zeta potential of −21.3 ± 2.1 mV, drug encapsulation of 85.4% ± 3.2% and loading capacity of 8.6% ± 0.4% (w/w), with ≤5% drug leakage over 14 days at 4°C. The FA-TLUM + US group achieved the highest tumour growth inhibition rate of 78.6%, significantly superior to other treatment groups (p < 0.001). Contrast-enhanced ultrasound imaging demonstrated enhanced signal intensity and prolonged retention time in targeted NMB groups. Quantitative PCR analysis revealed significant upregulation of pro-apoptotic genes (Bax increased 5.0-fold, caspase-3 increased 4.2-fold) and downregulation of anti-apoptotic genes (Bcl-2 decreased by 76%, survivin decreased by 72%) in the combination therapy group. The PTX@Fe3O4 NMBs combined with ultrasound therapy demonstrated potent antitumour efficacy through enhanced drug delivery and activation of mitochondrial apoptotic pathways, representing a promising theranostic platform for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelBreast NeoplasmsUltrasonic TherapyMagnetic Iron Oxide NanoparticlesAntineoplastic Agents, PhytogenicAnimalsFemaleHumansMiceMice, NudeMice, Inbred BALB CXenograft Model Antitumor AssaysApoptosisMCF-7 CellsCombined Modality TherapyFerric Compounds

Stichwörter der Autor:innen

apoptosisbreast canceriron oxidesmetal nanoparticlespaclitaxelultrasound therapy

Substanzen

PaclitaxelAntineoplastic Agents, Phytogenicferric oxideFerric Compounds

Autor:innen und Institutionen

  • Ultrasound Department, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar City, Heilongjiang Province161006, China.
  • Dialysis Room, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar City, Heilongjiang Province161006, China.
  • Basic Medical School, Qiqihar Medical University, Qiqihar City, Heilongjiang Province161006, China.
  • School of Medical Technology, Qiqihar Medical University, Qiqihar City, Heilongjiang Province161006, China.

ORCID-Profile: Xiaomei Ning

Förderung

  • Qiqihar Academy of Medical Sciences Clinical Research Fund Project

Zitieren

APA

Lv, W., Wang, Z., Huang, C., Li, X., Bai, L., Wang, X., Liu, H., Song, Y., Liu, B., & Ning, X. (2026). Inhibitory Effect and Mechanism of Paclitaxel-Loaded Magnetic Iron Oxide Nanomicrobubbles Combined with Ultrasound Therapy on Breast Cancer Xenografts in Nude Mice. Molecular Pharmaceutics, 23(11), 5250-5260. https://doi.org/10.1021/acs.molpharmaceut.5c01920

Vancouver

Lv W, Wang Z, Huang C, Li X, Bai L, Wang X, et al. Inhibitory Effect and Mechanism of Paclitaxel-Loaded Magnetic Iron Oxide Nanomicrobubbles Combined with Ultrasound Therapy on Breast Cancer Xenografts in Nude Mice. Molecular Pharmaceutics. 2026;23(11):5250-5260. doi:10.1021/acs.molpharmaceut.5c01920

BibTeX
@article{Lv2026,
  author = {Lv, Weiyang and Wang, Zihan and Huang, Chunxin and Li, Xing and Bai, Lianjie and Wang, Xiaotong and Liu, Huilin and Song, Yunna and Liu, Bowen and Ning, Xiaomei},
  title = {Inhibitory Effect and Mechanism of Paclitaxel-Loaded Magnetic Iron Oxide Nanomicrobubbles Combined with Ultrasound Therapy on Breast Cancer Xenografts in Nude Mice},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {5250--5260},
  doi = {10.1021/acs.molpharmaceut.5c01920}
}
Kostenlos starten →